Anti Cancer Medication

Approx. Rs 1,440 / 14 tabGet Latest Price

Tegafi 100Mg/224Mg Capsule is an antineoplastic agent used to treat malignant neoplasms and advanced colorectal cancer.

Let your doctor know if you are hypersensitive, pregnant, planning to become pregnant or are breastfeeding, if you’re taking any prescription or non-prescription drugs, herbal medicines and diet supplements. It is not to be used if you are malnourished, have renal impairment, a history of cardiac disease or an infection.

Tegafi 100Mg/224Mg Capsule can be given orally or intravenously. Never take a double dose of Tegafi 100Mg/224Mg Capsule, it is better that you skip it till the next time you take it. Remember to ask the doctor any queries that you may have about the medicine and the course of the treatment.

The side effects of Tegafi 100Mg/224Mg Capsule are hot flashes, oedema, itching, bone marrow depression, hemorrhage, alopecia, nausea and vomiting. While side effects do not happen to everybody, there is a slight possibility that they do, and it is important that you see a doctor when you notice such symptoms.

• Ovarian Cancer

• Head And Neck Cancer

• Cervical Cancer

• Testicular Cancer

• Breast Cancer

• Non-Hodgkin Lymphoma (Nhl)

• Blood Cancer

• Lung Cancer

• Bone Cancer

• Urinary Bladder Cancer

• Nausea

• Vomiting

• Weakness

• Loss Of Appetite

• Reduced Blood Platelets

• Increased Risk Of Infection

• Decreased White Blood Cell Count

• Bronchospasm

• Diarrhoea

• Stomatitis (Inflammation Of The Mouth)

• Esophagitis

• Inflammation Of The Rectum

Additional Information:

Approx. Rs 400 / VialGet Latest Price

Additional Information:

Approx. Rs 3,050 / StripGet Latest Price

Additional Information:

Approx. Rs 2,395 / BottleGet Latest Price

Additional Information:

Approx. Rs 8,000 / VialGet Latest Price

Additional Information:

Approx. Rs 2,695 / BoxGet Latest Price

Additional Information:

Approx. Rs 35,750 / BoxGet Latest Price

Vectibix (panitumumab) is a recombinant, human IgG2 kappa monoclonal antibody that binds specifically to the human epidermal growth factor receptor (EGFR). Panitumumab has an approximate molecular weight of 147 kDa. Panitumumab is produced in genetically engineered mammalian (Chinese hamster ovary) cells.

Vectibix is a sterile, colorless, pH 5.6 to 6.0 liquid for intravenous (IV) infusion, which may contain a small amount of visible translucent-to-white, amorphous, proteinaceous, panitumumab particulates. Each single-use 5 mL vial contains 100 mg of panitumumab, 29 mg sodium chloride, 34 mg sodium acetate, and Water for Injection, USP. Each single-use 10 mL vial contains 200 mg of panitumumab, 58 mg sodium chloride, 68 mg sodium acetate, and Water for Injection, USP. Each single-use 20 mL vial contains 400 mg of panitumumab, 117 mg sodium chloride, 136 mg sodium acetate, and Water for Injection, USP.

Vectibix is indicated for the treatment of patients with wild-type KRAS (exon 2 in codons 12 or 13) metastatic colorectal cancer (mCRC) as determined by an FDA-approved test for this use:

• As first-line therapy in combination with FOLFOX [see Clinical Studies].
• As monotherapy following disease progression after prior treatment with fluoropyrimidine-, oxaliplatin-, and irinotecan-containing chemotherapy

The recommended dose of Vectibix is 6 mg/kg, administered as an intravenous infusion over 60 minutes, every 14 days. If the first infusion is tolerated, administer subsequent infusions over 30 to 60 minutes. Administer doses higher than 1000 mg over 90 minutes [see Preparation and Administration].

Appropriate medical resources for the treatment of severe infusion reactions should be available during Vectibix infusions

100 mg panitumumab in 5 mL (20 mg/mL) single-use vial.

200 mg panitumumab in 10 mL (20 mg/mL) single-use vial.

400 mg panitumumab in 20 mL (20 mg/mL) single-use vial.

Approx. Rs 7,800 / UnitGet Latest Price

COMMON BRAND(S): Imbruvica
Ibrutinib 140 is used to treat certain cancers (such as mantle cell lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenstrom's macroglobulinemia). Ibrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells.

Ibrutinib is also used to treat a certain problem that may occur after a stem cell transplant (chronic graft versus host disease). It works by weakening your body's defense system (immune system).

Administer IMBRUVICA orally once daily at approximately the same time each day. The dose should be taken orally with a glass of water. Do not open, break, or chew the capsules. Do not cut, crush, or chew the tablets.

Product Price :Get Latest Price

Arimidex is a drug used to treat breast cancer after surgery and for metastases in both pre and post-menopausal women.

Below are the Competitors brands with D.Vijay Pharma Pvt. Ltd. kindly see the Table below.

Additional Information:

Product Price :Get Latest Price

Additional Information:

Product Price :Get Latest Price

Additional Information:

Product Price :Get Latest Price

• Pharmacy Medicine 
• Keep out of reach of children

Additional Information:

Product Price :Get Latest Price

• For intravenous infusion to hospitalized patients only
• Single dose vial

Additional Information:

Product Price :Get Latest Price

Available with us are highly effective medicines including Thalix, which is widely demanded in the market. These medicines ensure effective results, accurate formulation and safe usage. We supply these medicines to our clients spread all across the nation. These are sourced from reliable vendors of the industry, who hold vast experience in the domain. Thalix is available in the form of 50 mg capsule, 100 mg capsule and 200 mg capsule.

Additional Information:

Product Price :Get Latest Price

Additional Information: